NA

Naturalendo Tech Co., Ltd

Develops biotech products from endocrinology and herbal science for health markets.

168330 | KO

Overview

Corporate Details

ISIN(s):
KR7168330009
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 판교로 255 번길 58, 에이동 301호, 성남시

Description

Naturalendo Tech Co., Ltd. is a biotechnology company specializing in the research, development, manufacture, and sale of products derived from bio-sciences, endocrinology, and herbal science. The company's portfolio includes dietary supplements, healthcare products, and biological agents, with a particular focus on hormone-related biotechnology. Leveraging its research and development capabilities, Naturalendo Tech develops solutions for the health and beauty markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2020-02-14 00:00
내부결산시점관리종목지정ㆍ형식적상장폐지ㆍ상장적격성실질심사사유발생
Korean 24.9 KB
2020-02-14 00:00
주권매매거래정지(투자자 보호)
Korean 4.6 KB
2020-02-14 00:00
기타시장안내(상장적격성 실질심사 관련 상장폐지 우려 및 관리종목지정 사유추가 관련 안내)
Korean 4.6 KB
2019-12-13 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2019-11-14 00:00
분기보고서 (2019.09)
Korean 878.1 KB
2019-08-14 00:00
반기보고서 (2019.06)
Korean 923.4 KB
2019-06-10 00:00
대표이사변경
Korean 10.6 KB
2019-05-15 00:00
분기보고서 (2019.03)
Korean 1.1 MB
2019-03-29 00:00
사업보고서 (2018.12)
Korean 1.3 MB
2019-03-26 00:00
정기주주총회결과
Korean 20.4 KB
2019-03-18 00:00
감사보고서제출
Korean 26.4 KB
2019-03-05 00:00
주주총회집중일개최사유신고
Korean 5.1 KB
2019-03-05 00:00
주주총회소집공고
Korean 236.9 KB
2019-03-05 00:00
의결권대리행사권유참고서류
Korean 225.0 KB
2019-02-11 00:00
내부결산시점관리종목지정ㆍ형식적상장폐지ㆍ상장적격성실질심사사유발생
Korean 25.1 KB

Automate Your Workflow. Get a real-time feed of all Naturalendo Tech Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Naturalendo Tech Co., Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Naturalendo Tech Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.